Huma and UCB partner to provide digital health solution to improve management of the rare disease, Myasthenia gravis
(Adnkronos) – NEW YORK and LONDON, April 26, 2023 /PRNewswire/ — Huma Therapeutics (“Huma”), a leading global digital health company, and UCB, a global biopharmaceutical company, are partnering to offer a digital
